47.86
price up icon0.50%   0.24
 
loading
Schlusskurs vom Vortag:
$47.62
Offen:
$48.07
24-Stunden-Volumen:
5.61M
Relative Volume:
2.15
Marktkapitalisierung:
$121.02B
Einnahmen:
$48.62B
Nettoeinkommen (Verlust:
$6.80B
KGV:
17.07
EPS:
2.8038
Netto-Cashflow:
$7.62B
1W Leistung:
-3.64%
1M Leistung:
-9.51%
6M Leistung:
+0.31%
1J Leistung:
+2.16%
1-Tages-Spanne:
Value
$47.45
$48.11
1-Wochen-Bereich:
Value
$47.42
$50.18
52-Wochen-Spanne:
Value
$45.80
$60.12

Sanofi Adr Stock (SNY) Company Profile

Name
Firmenname
Sanofi Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
82,878
Name
Twitter
@sanofi
Name
Nächster Verdiensttermin
2024-10-25
Name
Neueste SEC-Einreichungen
Name
SNY's Discussions on Twitter

Vergleichen Sie SNY mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - General icon
SNY
Sanofi Adr
47.86 121.02B 48.62B 6.80B 7.62B 2.8038
Drug Manufacturers - General icon
LLY
Lilly Eli Co
762.73 724.64B 49.00B 11.11B -1.27B 12.29
Drug Manufacturers - General icon
JNJ
Johnson Johnson
149.79 376.43B 89.33B 21.81B 18.57B 8.99
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
73.77 352.49B 43.59B 15.04B 10.74B 3.3766
Drug Manufacturers - General icon
ABBV
Abbvie Inc
185.30 334.73B 57.37B 4.20B 15.39B 2.35
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
115.77 234.21B 53.22B 12.86B 14.85B 6.39

Sanofi Adr Stock (SNY) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-15 Eingeleitet Exane BNP Paribas Outperform
2025-03-21 Eingeleitet Goldman Neutral
2025-01-30 Hochstufung Deutsche Bank Sell → Hold
2024-07-26 Bestätigt Argus Buy
2024-01-23 Eingeleitet Morgan Stanley Equal-Weight
2024-01-16 Fortgesetzt UBS Buy
2023-12-05 Herabstufung JP Morgan Overweight → Neutral
2023-10-30 Herabstufung Stifel Buy → Hold
2023-09-06 Hochstufung Berenberg Hold → Buy
2023-07-14 Eingeleitet HSBC Securities Buy
2023-04-28 Herabstufung Deutsche Bank Hold → Sell
2023-03-27 Hochstufung Barclays Equal Weight → Overweight
2022-12-13 Fortgesetzt Morgan Stanley Overweight
2022-08-12 Hochstufung Deutsche Bank Sell → Hold
2022-08-09 Herabstufung UBS Buy → Neutral
2022-05-23 Eingeleitet SVB Leerink Outperform
2021-09-27 Hochstufung SVB Leerink Mkt Perform → Outperform
2021-01-15 Eingeleitet Deutsche Bank Sell
2020-09-29 Eingeleitet Berenberg Hold
2020-03-17 Hochstufung Barclays Underweight → Equal Weight
2020-03-11 Hochstufung Goldman Neutral → Buy
2020-02-11 Eingeleitet SVB Leerink Mkt Perform
2020-01-06 Hochstufung JP Morgan Neutral → Overweight
2019-09-23 Hochstufung Guggenheim Neutral → Buy
2019-09-20 Hochstufung Morgan Stanley Equal-Weight → Overweight
2019-09-03 Eingeleitet Bernstein Outperform
2019-08-14 Hochstufung UBS Neutral → Buy
2018-12-11 Hochstufung Jefferies Hold → Buy
2018-11-01 Hochstufung Barclays Underweight → Equal Weight
2018-10-09 Eingeleitet Guggenheim Neutral
2018-09-10 Hochstufung BofA/Merrill Neutral → Buy
2018-08-10 Hochstufung Citigroup Neutral → Buy
2018-03-23 Hochstufung Liberum Hold → Buy
2018-01-23 Herabstufung Barclays Equal Weight → Underweight
2017-12-06 Herabstufung BofA/Merrill Buy → Neutral
2017-12-01 Herabstufung Morgan Stanley Overweight → Underweight
2017-11-15 Hochstufung Barclays Underweight → Equal Weight
2017-08-30 Hochstufung HSBC Securities Reduce → Hold
Alle ansehen

Sanofi Adr Aktie (SNY) Neueste Nachrichten

pulisher
Jun 18, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SanofiSNY - FinancialContent

Jun 18, 2025
pulisher
Jun 15, 2025

Communiqué : Dupixent a démontré sa supériorité par rapport au Xolair dans la rhinosinusite chronique avec polypes nasaux chez des patients atteints d’asthme coexistant dans la toute 1ere étude respiratoire de ph4 en comparaison directe … - GlobeNewswire Inc.

Jun 15, 2025
pulisher
Jun 13, 2025

SNY’s 2023 Market Dance: Up 3.92% – Time to Invest? - investchronicle.com

Jun 13, 2025
pulisher
Jun 09, 2025

Sanofi: Information concerning the total number of voting rights and shares - GlobeNewswire Inc.

Jun 09, 2025
pulisher
Jun 02, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

Jun 02, 2025
pulisher
Jun 02, 2025

France’s Sanofi to buy U.S. biopharma group Blueprint for up to $9.5-billion - The Globe and Mail

Jun 02, 2025
pulisher
Jun 02, 2025

Sanofi doubles down on immunology with $9.1bn Blueprint deal - Proactive financial news

Jun 02, 2025
pulisher
May 31, 2025

European ADR Index Slips As Pharma Stocks Buck The Trend - Finimize

May 31, 2025
pulisher
May 30, 2025

Regeneron and Sanofi: Disappointing Top-Line Results for Itepekimab From Two Phase 3 Trials - Morningstar

May 30, 2025
pulisher
May 30, 2025

Regeneron Pharmaceuticals Crashes 19% On A Surprise Sanofi-Tied Failure - Investor's Business Daily

May 30, 2025
pulisher
May 30, 2025

Market movers: Canopy Growth, Zscaler, Regeneron... - Proactive financial news

May 30, 2025
pulisher
May 30, 2025

Regeneron shares plunge after mixed COPD drug trial results - Proactive financial news

May 30, 2025
pulisher
May 29, 2025

Penicillin Market Research Report 2025 - GlobeNewswire Inc.

May 29, 2025
pulisher
May 26, 2025

Prurigo Nodularis Market - GlobeNewswire Inc.

May 26, 2025
pulisher
May 23, 2025

8MM Bronchiectasis Market Opportunity Assessment and Forecasts, 2033 - GlobeNewswire Inc.

May 23, 2025
pulisher
May 22, 2025

Dollar Stock Biotech Triples On $470 Million Sanofi Takeover - Investor's Business Daily

May 22, 2025
pulisher
May 08, 2025

Metric Deep Dive: Understanding Sanofi ADR (SNY) Through its Ratios - DWinneX

May 08, 2025
pulisher
May 02, 2025

iRhythm Technologies Inc (IRTC) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

WLK’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

BIDU’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

A Tale of Resilience: Sanofi ADR Amid Stock Market Turbulence - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Company’s Banking Stock: Dissecting a 40.08% Quarterly Revenue Decline Amid Growth - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Trip.com Group Ltd ADR (TCOM) Stock: A Year of Stock Market Ups and Downs - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

CYTK’s 2023 Market Dance: Down -21.41% – Time to Invest? - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

CIG’s Market Whiplash: 8.19% YTD Rise, 9.30% Rise in 30 Days - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Can Navitas Semiconductor Corp Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

LX’s 2023 Market Dance: Up 43.28% – Time to Invest? - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Terex Corp (TEX) Stock: 52-Week Performance Insights and Trading Volume - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Behind Cytosorbents Corp’s 52-Week Range: Uncovering Opportunities for Investors - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Procore Technologies Inc (PCOR) Stock: A 52-Week Tale of Drops and Gains - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Navigating TREE Stock: LendingTree Inc Journey - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Companhia Siderurgica Nacional ADR (SID) Stock: From Low to High in 52 Weeks - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

The Future of EVgo Inc: Analyzing EVGO - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Analyzing the Impact of Earnings Reports on Sunstone Hotel Investors Inc Inc. (SHO) Price Performance - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

NVS’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Unilever plc ADR: Rising -3.90% from 52-Week Low, Can the Stock Stay Afloat? - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

TTWO’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Futu Holdings Ltd ADR (FUTU) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Stryker Corp (SYK) Stock: Navigating a Year of Volatility - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Viking Holdings Ltd’s Banking’s 100-Day Moving Average at 44.43: Will the Stock Break Through? - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

CTRE’s Market Whiplash: 5.78% YTD Rise, 0.22% Rise in 30 Days - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Sandisk Corp (SNDK) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

LSCC: Riding the Market Waves of Growth and Decline in 2023 - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Canadian National Railway Co: Navigating Market Fluctuations with a 62.62B Market Cap - investchronicle.com

May 02, 2025

Finanzdaten der Sanofi Adr-Aktie (SNY)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$108.50
price up icon 0.46%
drug_manufacturers_general PFE
$23.97
price up icon 0.38%
$289.33
price down icon 0.10%
drug_manufacturers_general MRK
$79.06
price down icon 0.29%
drug_manufacturers_general NVS
$115.77
price down icon 0.16%
Kapitalisierung:     |  Volumen (24h):